Sign in
4

Changes in Ownership

Harmony Biosciences Holdings, Inc. Filed Acc 0001415889-25-001931

PRESIDENT, CEO sold 19,293 shares at $40.13 ($774,245)

  • PRESIDENT, CEO acquired 19,293 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dayno Jeffrey M. PRESIDENT, CEO 2025-01-21 Option exercise 10b5-1 +19,293 $8.22 $158,588 19,293 D
Dayno Jeffrey M. PRESIDENT, CEO 2025-01-21 Sale 10b5-1 −19,293 $40.13 $774,245 0 D
Derivatives
Dayno Jeffrey M. PRESIDENT, CEO 2025-01-21 Option exercise · Stock Option 10b5-1 −3,470 20,000 D
Dayno Jeffrey M. PRESIDENT, CEO 2025-01-21 Option exercise · Stock Option 10b5-1 −6,086 0 D
Dayno Jeffrey M. PRESIDENT, CEO 2025-01-21 Option exercise · Stock Option 10b5-1 −9,737 2,435 D
Open-market sales · 19,293 sh · avg $40.13 · $774,245
Loading xslF345X05/form4-01232025_090139.xml…